These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The successful conversion to Tacrolimus (FK506) of a renal transplant recipient with cyclosporin-induced haemolytic-uraemic syndrome. Richardson D; Jones CH; Newstead CG; Will EJ; Lodge JP Nephrol Dial Transplant; 1996 Dec; 11(12):2498-500. PubMed ID: 9017633 [No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil as an effective alternative to cyclosporin in post-transplant haemolytic uraemic syndrome. Agarwal DK; Gulati S; Mehta A; Kumar A; Sharma RK; Mehta B; Gupta A; Gupta RK Nephrol Dial Transplant; 2000 Dec; 15(12):2064-5. PubMed ID: 11096161 [No Abstract] [Full Text] [Related]
8. Development of transplant renal artery thrombosis and signs of haemolytic-uraemic syndrome following the change from cyclosporin to tacrolimus in a renal transplant patient. Kiykim AA; Ozer C; Yildiz A; Tiftik N; Senli M; Kelebek E; Doruk E; Akbay E Nephrol Dial Transplant; 2004 Oct; 19(10):2653-6. PubMed ID: 15388824 [No Abstract] [Full Text] [Related]
10. Cyclosporin-induced haemolytic-uraemic syndrome presenting as primary graft dysfunction. Kohli HS; Sud K; Jha V; Gupta KL; Minz M; Joshi K; Sakhuja V Nephrol Dial Transplant; 1998 Nov; 13(11):2940-2. PubMed ID: 9829509 [No Abstract] [Full Text] [Related]
11. Uneventful re-treatment with cyclosporin in two cases of cyclosporin-induced haemolytic uraemic syndrome. Guella A; Daoud M; Al Dayel A Nephrol Dial Transplant; 1998 Jul; 13(7):1864-5. PubMed ID: 9681750 [No Abstract] [Full Text] [Related]